Skip to main content

Recursion Pharmaceuticals, Inc 10-Q for FY2022 Q2

Recursion Pharmaceuticals, Inc. (RXRX)

10-Q 2022-08-09 For: 2022-06-30
View Original
Added on April 10, 2026

About this 10-Q

Recursion Pharmaceuticals, Inc filed this 10-Q on August 9, 2022, covering the quarter ended June 30, 2022 (FY2022 Q2).

Headline figures

Quarter ended June 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$7.67M
up 201.1% from $2.55M a year earlier
Net loss
$65.56M
compared with a net loss of $43.4M a year earlier
Diluted EPS
-$0.38